Home

Seokho Bryan Yoon

CIK 1761164 · COO and General Counsel · last filed 2024-06-04

Seokho Bryan Yoon is a COO and General Counsel who has filed 14 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for TERN, was dated Sep 10, 2024. Across all open-market trades the lifetime net is +$49.4K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

14

Lifetime Open-Market Net

$49.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Terns Pharmaceuticals, Inc. (TERN) Delisted COO and General Counsel 91,940 $52.95 $4.87M $49.4K 8 2024-06-04
LogicBio Therapeutics, Inc. (LOGC) Delisted Chief Admin Officer & GC — $7.06 — $0 3 2020-04-17
NITE General Counsel and Secretary — $35.01 — $0 2 2019-06-07

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-09-10 Terns Pharmaceuticals, Inc. (TERN) Delisted Notice (144) −10,000 -$91.2K EDGAR
2024-06-04 Terns Pharmaceuticals, Inc. (TERN) Delisted Buy (P) +4,791 $21.3K EDGAR
2024-01-25 Terns Pharmaceuticals, Inc. (TERN) Delisted Grant (A) +68,750 $0 EDGAR
2023-12-04 Terns Pharmaceuticals, Inc. (TERN) Delisted Buy (P) +743 $2.8K EDGAR
2023-06-02 Terns Pharmaceuticals, Inc. (TERN) Delisted Buy (P) +9,997 $14.1K EDGAR
2023-02-03 Terns Pharmaceuticals, Inc. (TERN) Delisted Mixed +3 $4 EDGAR
2022-06-08 Terns Pharmaceuticals, Inc. (TERN) Delisted Buy (P) +7,656 $11.3K EDGAR
2022-01-28 Terns Pharmaceuticals, Inc. (TERN) Delisted Grant (A) — $0 EDGAR
2021-09-30 Terns Pharmaceuticals, Inc. (TERN) Delisted Grant (A) — $0 EDGAR
2020-04-17 LogicBio Therapeutics, Inc. (LOGC) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.